OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults

Clinical trial NCT05949424 · UNKNOWN

Trial details

NCT number: NCT05949424
Sponsor: University Medical Center Groningen
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Renal Cell Carcinoma Ovarian Carcinoma Thyroid Carcinoma Breast Carcinoma Endometrium Carcinoma

Start date: 2024-05-01
Primary completion: 2025-03-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.